IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.519
EU - Europa 2.820
AS - Asia 2.151
SA - Sud America 841
AF - Africa 51
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.464
SG - Singapore 946
IE - Irlanda 759
BR - Brasile 756
SE - Svezia 684
CN - Cina 609
UA - Ucraina 337
HK - Hong Kong 300
DE - Germania 297
IT - Italia 182
FI - Finlandia 149
GB - Regno Unito 122
RU - Federazione Russa 103
VN - Vietnam 81
PL - Polonia 67
IN - India 46
FR - Francia 32
AR - Argentina 26
BD - Bangladesh 24
CA - Canada 23
AT - Austria 21
MX - Messico 20
TR - Turchia 19
IQ - Iraq 17
BE - Belgio 16
EC - Ecuador 16
PK - Pakistan 16
UZ - Uzbekistan 16
MA - Marocco 15
VE - Venezuela 12
KE - Kenya 11
NL - Olanda 11
IR - Iran 10
ID - Indonesia 9
JP - Giappone 9
CO - Colombia 8
CZ - Repubblica Ceca 7
LT - Lituania 7
ZA - Sudafrica 7
AU - Australia 6
CL - Cile 6
PY - Paraguay 6
EG - Egitto 5
ES - Italia 5
KR - Corea 5
PE - Perù 5
TN - Tunisia 5
IL - Israele 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
UY - Uruguay 3
BN - Brunei Darussalam 2
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.391
Salva come PNG Salva come JPEG
Città #
Dublin 759
Jacksonville 617
Chandler 600
Dallas 517
Nyköping 437
Singapore 429
Ashburn 407
Dearborn 390
Hong Kong 300
Beijing 293
Princeton 120
Medford 116
Cambridge 109
Los Angeles 104
Ann Arbor 81
Boardman 78
Munich 78
The Dalles 77
Des Moines 72
Warsaw 65
Buffalo 61
Messina 57
New York 50
São Paulo 49
Ho Chi Minh City 39
San Mateo 34
Woodbridge 33
Turku 31
Jinan 30
Wilmington 28
Moscow 26
Tianjin 26
Lancaster 23
Belo Horizonte 21
Vienna 19
Rio de Janeiro 18
Seattle 18
Phoenix 17
Redondo Beach 17
Brussels 16
Haikou 15
Santa Clara 15
Brasília 13
Houston 13
Nanjing 13
Tashkent 13
Salvador 12
Shenyang 12
Boston 11
Curitiba 11
Hefei 11
Taizhou 11
Düsseldorf 10
Francofonte 10
Hebei 10
Stockholm 10
Taiyuan 10
Washington 10
Atlanta 9
Chennai 9
Denver 9
Guangzhou 9
London 9
Montreal 9
Sorocaba 9
Tokyo 9
Ardabil 8
Baghdad 8
Fuzhou 8
Helsinki 8
Milan 8
Nairobi 8
Nanchang 8
Pune 8
San Francisco 8
Campinas 7
Columbus 7
Contagem 7
Dhaka 7
Frankfurt am Main 7
Hanoi 7
Mumbai 7
Orem 7
Auburn Hills 6
Brooklyn 6
Changsha 6
Charlotte 6
Chicago 6
Fortaleza 6
Goiânia 6
Guarulhos 6
Istanbul 6
Jakarta 6
Johannesburg 6
Mexico City 6
Norwalk 6
Piracicaba 6
Poplar 6
Porto Alegre 6
Praia Grande 6
Totale 6.774
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 168
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 145
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 135
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 130
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 129
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 129
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 128
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 127
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 124
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 124
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 120
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 119
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 119
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 119
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 118
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 116
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 116
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 115
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 115
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 113
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 113
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 111
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 110
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 109
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 108
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 108
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 106
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 106
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 104
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 104
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 103
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 101
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 101
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 99
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 98
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 97
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 96
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 96
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 95
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 95
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 94
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 93
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 93
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 93
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 92
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 91
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 91
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 90
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 90
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 89
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 89
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 87
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 87
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 87
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 86
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 86
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 85
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 85
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 85
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 85
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 84
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 83
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 82
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 82
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 81
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 81
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 81
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 81
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 81
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 80
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 80
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 80
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 80
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 79
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 79
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 79
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 79
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 78
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 77
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 77
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 77
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 77
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 76
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 76
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 76
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 75
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 75
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 74
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 73
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 73
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 73
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 72
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 71
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 71
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 70
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 69
Chondroprotective activity of 5-arylidene-4-thiazolidinone derivatives as new inhibitors of matrix metalloproteinase-13 68
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 68
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 67
Synthesis of mono- and di-cyanoborane adducts from isonicotinoylhydrazones and sodium cyanoborohydride 66
Totale 9.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 99 12 82 28 105 83 39
2021/2022700 6 100 13 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/20252.140 21 21 41 135 82 38 57 445 578 128 188 406
2025/20262.331 304 501 483 477 513 53 0 0 0 0 0 0
Totale 10.474